SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of July 2005
FRESENIUS MEDICAL CARE CORPORATION
-----------------------------------------------
(Translation of registrant's name into English)
Else-Kroner Strasse 1
61346 Bad Homburg
Germany
----------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes [ ] No [X]
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82
Attached hereto as Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3 are the
uncertified English translations of the of the following documents relating to
the Extraordinary General Meeting to be held August 30, 2005:
Conversion Report on the Conversion of Preference Shares into Ordinary
Shares
Report on the Reasons for the Exclusion of the Pre-emptive Rights in
Connection with the Creation of Authorized Capital
Transformation report setting forth the reasons for the transformation.
EXHIBITS
Exhibit 99.1 Uncertified English translation of the Conversion Report on the
Conversion of Preference Shares into Ordinary Shares
Exhibit 99.2 Uncertified English translation of Report on the Reasons for the
Exclusion of the Pre-emptive Rights in Connection with the
Creation of Authorized Capital
Exhibit 99.3 Uncertified English translation of Transformation report setting
forth the reasons for the transformation.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DATE: July 26, 2005
FRESENIUS MEDICAL CARE
AKTIENGESELLSCHAFT
By: /s/ DR. BEN LIPPS
---------------------------------------
Name: Dr. Ben Lipps
Title: Chief Executive Officer and
Chairman of the Management Board
By: /s/ LAWRENCE A. ROSEN
---------------------------------------
Name: Lawrence A. Rosen
Title: Chief Financial Officer
3